Ray Zadegan, MD, FACC 
Program Director, Interventional Cardiology

Medical School:  Medical College of Wisconsin
Residency Training: UCLA
Fellowship Training: Kaiser Permanente Los Angeles Medical Center (Cardiology, Interventional Cardiology)
Academic Appointments: Clinical Assistant Professor of Medicine, David Geffen School of Medicine at UCLA
Other: Dr. Zadegan graduated from the Medical College of Wisconsin. He completed Internal Medicine residency at the UCLA Medical center in 2002. He received further training in Cardiovascular Diseases and Interventional Cardiology Fellowships at Kaiser LAMC. He then completed a mini-fellowship in Endovascular Therapies of Peripheral Arterial Disease at Colombia University Medical Center. Upon completion of his Endovascular Fellowship, he worked in both private (SanSum Clinic in Santa Barbara) and academic (UCLA Medical Center) practice settings as an interventional cardiologist. In 2011, he joined the LAMC faculty in the Cardiac Cath Lab as a full time Cath Lab and Interventional Staff Cardiologist.

Somjot (Sam) S. Brar, MD, MPH, FACC
Director, Regional Cardiac Cath Lab
Assistant Clinical Prof. of Medicine, UCLA

Medical School: Sackler School of Medicine, Israel and New York
Residency Training: Kaiser Oakland
Fellowship Training: Kaiser Permanente Los Angeles Medical Center (CVD); Columbia University (IC)
Academic Appointments: Clinical Assistant Professor of Medicine, David Geffen School of Medicine at UCLA
Board Certifications: Internal Medicine, Cardiology, Interventional Cardiology
Other: Dr. Brar completed Internal Medicine residency and chief residency at Kaiser Oakland, CVD fellowship at LAMC, and cardiovascular interventional training at the Center for Interventional Vascular Therapy of Columbia University Medical Center & the Cardiovascular Research Foundation (CRF). He received the Master of Public Health degree from the Harvard School of Public Health. He is board certified in Internal Medicine, Cardiology, and Interventional Cardiology. Dr. Brar joined the LAMC faculty upon completion of fellowship training in 2009. He also serves as LAMC Director of Vascular & Endovascular Medicine and performs percutaneous peripheral vascular, structural, and coronary interventions. He also performs complex aortic interventions such as thoracic endovascular aortic aneurysm and aortic dissection repair. In 2018, he was appointed as the Director of the Interventional Cardiology Fellowship and Regional Cardiac Catheterization Laboratory at Kaiser, Los Angeles Medical Center (KP-LAMC). Dr. Brar is the author of 100+ original research manuscripts, meta-analyses, review articles, editorials, and abstracts. Dr. Brar has expertise in designing, conducting, and reporting clinical trials and has given multiple “late breaking” clinical trial presentations at major scientific meetings. He is the senior author for publications in leading journals including the Lancet and JAMA. Dr. Brar is a reviewer/editorial consultant for 40+ medical journals, including the Lancet, JAMA, JACC, EHJ, Circulation, and serves as a member of the editorial board for 10+ journals. He is currently serving as an Associate Director for Transcatheter Cardiovascular Therapeutics, the largest national interventional cardiology meeting, and has served as faculty for various meetings including the American College of Cardiology (ACC) Scientific Sessions, and the Society of Cardiac Angiography & Interventions. He is also serving on the research & publications committee for the ACC’s CathPCI registry that is part of the National Cardiovascular Data Registry, and is one of the authors drafting CathSAP5, the ACC’s premier educational resource for Interventional Cardiology. As the Chair of the Regional Research Committee for Kaiser Permanente Southern California, Dr. Brar oversees the administration of >$500,000 in research grants annually, develops educational programs to promote clinical research, and assists investigators with protocol and analytic plan development throughout the Southern California region. Dr. Brar also serves on the regional Medical Technology Assessment Team, evaluating novel and cutting-edge therapies for use in Kaiser Permanente Southern California, and is a member of the Institutional Review Board.

Naing Moore, MD,MRCP (UK), FSCAI
Interventional Cardiologist, KPSC Regional Cardiac Cath Lab

Medical School: University of Medicine, Mandalay, Myanmar
Residency Training: St. Lukes Hospital and Bradford Royal Infirmary, Watford General Hospital, Mount Vernon Hospital, West Middlesex University Hospital (UK); Seton Hall University (US)
Fellowship Training: Kaiser Permanente Los Angeles Medical Center (Cardiology, Interventional Cardiology)
Clinical Interests: Clinical Assistant Professor of Medicine, David Geffen School of Medicine at UCLA
Board Certifications: Internal Medicine, Cardiology, Interventional Cardiology
Other: Dr. Moore received MD degree from the University of Medicine, Mandalay, Myanmar in 1991. From 1992-1996, he underwent Internal Medicine postgraduate training in the United Kingdom at St. Lukes Hospital and Bradford Royal Infirmary in West Yorkshire, Watford and Mount Vernon Hospitals in Middlesex, London and West Middlesex University Hospital in Isleworth, West London. During post graduate training, he received his MRCP diploma from the Royal College of Physicians (London) in 1995. In United States, Dr. Moore completed Internal Medicine residency at Seton Hall University in New Jersey while serving as an Associate Chief Resident during his 3rd year, and both Cardiology and Interventional Cardiology fellowship at Kaiser LAMC. He joined the Interventional Cardiology Fellowship Program at LAMC as a faculty member in 2006. He is Clinical Assistant Professor at UCLA School of Medicine.

Prakash Mansukhani, MD, FACC, FSCAI 
Interventional Cardiologist, Regional Cardiac Catherization Laboratory

Medical School: Grant Medical College, Bombay University, India
Residency Training:  Coney Island Hospital, New York
Fellowship Training: Kaiser Permanente Los Angeles Medical Center
Academic Appointments: Clinical Assistant Professor of Medicine, David Geffen School of Medicine at UCLA
Board Certifications:  Internal Medicine, Cardiology, Interventional Cardiology
Other: Dr. Mansukhani received his Medical degree from Bombay University, India. He completed his Internal Medicine residency at Coney Island Hospital in New York and his Cardiology Fellowship at Kaiser, LAMC. He served as the Director of Cardiac transplant services from 1994-2004. He was the Associate Director of the Regional Cardiac Catheterization Laboratory from 1994-2015 and as the Director since 2016. He is a Clinical Assistant Professor at UCLA and has broad research interests in Interventional cardiology. He has authored/co-authored multiple abstracts and manuscripts and participated in multiple clinical trials. He has a vast experience in Interventional cardiology including structural heart disease such as Percutaneous Mitral Valvuloplasty, PFO Closures, Alcohol Septal Ablation and TAVR.

Albert Yuh-Jer Shen, MS, MD, FACC

Medical School: China Medical University, Taiwan
Residency Training: LAC-USC Medical Center
Fellowship Training: Kaiser Permanente Los Angeles Medical Center
Clinical Interests: Atrial Fibrillation Epidemiology, Anticoagulation, Coronary Artery Disease, Race/Ethnicity Disparity
Board Certifications: Cardiology, Interventional Cardiology
Other: Dr. Shen earned his medical degree (MD) from China Medical University (nee College) in Taiwan in 1988. He immigrated to the US in 1989 and earned a Master of Science (MS) degree in Anatomy and Cell Biology from USC in 1991. He completed Internal Medicine internship & residency training at LAC-USC (1994), followed by Cardiovascular Diseases (1997) and Interventional Cardiology (1998) fellowship training at Kaiser Permanente Los Angeles Medical Center (LAMC). Dr. Shen joined the LAMC faculty in 1999 upon completing fellowship training. He was the medical director of the 32 bed CCU for over a decade beginning in 2001. He served as the Assistant CVD Program Director 2001-4, and then became Program Director in 2004. He was appointed Chief of Cardiology in 2012, and continues to practice both general and interventional cardiology. He received both the 2008 Southern California Permanente Medical Group (SCPMG) Faculty of the Year Award and the 2008 SCPMG Researcher of the Year Award, the highest teaching and clinical research recognitions within KP So Cal, respectively. --- Dr. Shen is a Clinical Professor of Medicine at UCLA. His research interests are in atrial fibrillation epidemiology and racial/ethnic disparities in the treatments and outcomes of anticoagulation therapy for stroke prevention. He served as the Area Research Chairman for LAMC 2008-13, with overall responsibility for all research activities at the KP LA medical center. He has co-authored 20+ peer-reviewed manuscripts (published in JAMA, Lancet, JACC, Stroke, Archives of Dermatology, AJC, etc) and 60+ abstracts presented at national (e.g., ACC, AHA, TCT, etc) and international (e.g., CardioStim) conferences. He serves as peer reviewer/editorial consultant for 20+ indexed medical journals covering a broad range of disciplines (e.g., Circulation, Circ A&E, JTH, AJC, European J of Neurology, European J of Echocardiography, Rheumatology, Neurology, etc). He was a co-investigator on studies funded by the NIH and private foundations and has been Chairman of the annual national Kaiser CV Symposium (COAST) for the past decade.

Vicken J. Aharonian, MD, FACC, FCCP, FSCAI 
Interventional Cardiologist, Regional Cardiac Catherization Laboratory

Medical School: American University of Beirut, Lebanon
Residency Training: Rutgers Medical School, New Jersey, NJ
Fellowship Training: Case Western Reserve University, Cleveland OH
Academic Appointments: Clinical Associate Professor of Medicine, David Geffen School of Medicine at UCLA
Board Certifications: Internal Medicine, Cardiology, Interventional Cardiology
Other: Dr. Aharonian completed his Internal Medicine residency training in New Jersey and his Cardiology Fellowship training at Case Western Reserve University in Cleveland, Ohio . He was the Director of the Regional Cardiac Catheterization Laboratory at Kaiser, Los Angeles Medical Center (KP-LAMC) 1992-2015. He is Clinical Associate Professor of Medicine at UCLA. His research interest is in all aspects of Interventional Cardiology - including coronary interventions and structural heart disease. Dr. Aharonian initiated several interventional procedures at KP LAMC, including Mitral Valvuloplasty (1988), Directional Atherectomy (1991), Rotational Atherectomy (1993), Flow Wire (1997) and Pressure Wire, PFO closure (2005), Alcohol Septal Ablation for Hypertrophic Cardiomyopathy (2004), and CoreValve TAVI - as site Principal Investigator of the US Pivotal trial (2011).

Kathleen Ryman, MD

Medical School: Dartmouth
Residency Training: Dartmouth
Fellowship Training: Cardiology - Dartmouth Interventional Cardiology - New York Medical College